Vontobel Holding
RARE icon

Vontobel Holding’s Ultragenyx Pharmaceutical RARE Stock Holding History

Vontobel Holding’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,935
Closed -$329K – 1510
2025
Q3 		$329K Buy
10,935
+471
+5% +$14.1K ﹤0.01% 1073
2025
Q2 		$380K Buy
+10,464
New +$377K ﹤0.01% 978
2023
Q2 		– Sell
-28,424
Closed -$1.14M – 1140
2023
Q1 		$1.14M Sell
28,424
-4,494
-14% -$193K 0.01% 548
2022
Q4 		$1.53M Buy
+32,918
New +$1.29M 0.02% 476
2021
Q4 		– Sell
-13,382
Closed -$1.21M – 1183
2021
Q3 		$1.21M Sell
13,382
-319
-2% -$28.8K 0.01% 571
2021
Q2 		$1.31M Buy
+13,701
New +$1.43M 0.01% 537

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vontobel Holding's RARE Position: Q4 2025 in Review

Vontobel Holding sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2025, closing a stake of 10,935 shares — an estimated $329K sold.

Vontobel Holding first reported a position in RARE in Q2 2021 and held it in 6 quarters. The position peaked at $1.53M in Q4 2022. 288 funds tracked by Wall St. Rank hold RARE as of Q4 2025.

  • Vontobel Holding reported no remaining Ultragenyx Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Vontobel Holding sold 10,935 Ultragenyx Pharmaceutical shares in Q4 2025, an estimated $329K.
  • Vontobel Holding first reported a position in Ultragenyx Pharmaceutical in Q2 2021 and held it in 6 quarters.
  • Vontobel Holding's Ultragenyx Pharmaceutical position peaked at $1.53M in Q4 2022.
  • 288 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2025.

Based on Vontobel Holding's 13F filing for Q4 2025, filed 13 Feb 2026.